HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Metin Demircin lhan Paaolu Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Sarigül, A. Articles by Paaolu, I. Search for Related Content PubMed Articles by Sarigül, A. Articles by Paaolu, I.

Subxiphoid Approach for Treatment of Pericardial Effusion

Ali Sarigül, MD, Bora Farsak, MD, M anser Ate, MD, Metin Demircin, MD, lhan Paaolu, MD

Department of Thoracic and Cardiovascular Surgery Faculty of Medicine, Hacettepe University Ankara, Turkey

For reprint information contact: Ali Sarigül, MD Tel: 90 312 490 6076 Fax: 90 312 490 5612 email: whotur{at}dominet.in.com.tr Yesilyurt Sokak, No. 7/3, Cankaya, Ankara 06680, Turkey.

Subxiphoid pericardiotomy was the primary treatment in 305 patients with pericardial effusion from January 1984 to June 1996. There were 198 males and 107 females, ages ranged from 15 days to 75 years. The procedure was carried out with local anesthesia and sedation in 263 (86.2%) patients and under general anesthesia in 42 (13.8%). Median drainage was 975.25 ± 48.46 mL in 264 patients with benign effusion and 1131.25 ± 97.48 mL in 41 (13.4%) with malignant disease; cytology was positive in 14 of 38 (36.8%) and pericardial biopsy showed cancer in 12 of 36 (33.3%). Intraoperative complications in 22 patients (7.2%) included cardiac arrest in 12 (3.9%) of whom, 7 (2.3%) died. Overall 30-day mortality was 16.3%; it was 46.3% (19/41) in malignant cases versus 11.7% (31/264) in cases of benign effusion. Follow-up of 234 (91.8%) hospital survivors for 18 ± 3.62 months (range, 2 to 54 months) showed recurrent pericardial effusion needing further intervention in 31 (13.2%) of whom, 8 had cancer and 23 had benign disease. Median survival in benign cases was more than 107 days versus 56 days in malignant cases. Because of its acceptable mortality and morbidity, subxiphoid pericardiotomy is recommend as an initial procedure.